|
|
|
Insider
Information: |
Odonnell Niall |
Relationship: |
Director |
City: |
St. Louis |
State: |
MO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
5,136,136 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$4,005,345 |
|
|
Total
Shares |
5,136,136 |
|
|
Total
Value |
$4,005,345 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
Director |
|
0 |
2022-11-15 |
1,621,118 |
Premium* |
|
Spruce Biosciences, Inc. |
SPRB |
Director |
2020-10-14 |
0 |
2023-02-16 |
1,326,305 |
Premium* |
|
Reneo Pharmaceuticals, Inc. |
RPHM |
Director |
2021-04-13 |
0 |
2023-05-08 |
2,188,713 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MIRM |
Mirum Pharmaceuticals, In... |
Director |
|
2019-07-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
125,000 |
|
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Director |
|
2019-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,496,118 |
1,621,118 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Director |
|
2019-07-22 |
4 |
B |
$15.00 |
$4,500,000 |
I/I |
300,000 |
1,921,118 |
2.1 |
- |
|
SPRB |
Spruce Biosciences, Inc. |
Director |
|
2020-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
445,905 |
445,905 |
0 |
- |
|
SPRB |
Spruce Biosciences, Inc. |
Director |
|
2020-10-14 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
695,905 |
2.1 |
- |
|
RPHM |
Reneo Pharmaceuticals, In... |
Director |
|
2021-04-13 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
2,063,713 |
2.1 |
% |
|
RPHM |
Reneo Pharmaceuticals, In... |
Director |
|
2021-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,863,713 |
1,863,713 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Director |
|
2022-11-11 |
4 |
S |
$19.99 |
$3,481,410 |
I/I |
(174,121) |
1,746,997 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Director |
|
2022-11-14 |
4 |
S |
$19.60 |
$629,423 |
I/I |
(32,109) |
1,714,888 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Director |
|
2022-11-15 |
4 |
S |
$19.69 |
$1,846,022 |
I/I |
(93,770) |
1,621,118 |
0 |
- |
|
SPRB |
Spruce Biosciences, Inc. |
Director |
|
2023-02-16 |
4 |
B |
$3.17 |
$1,998,368 |
I/I |
630,400 |
1,326,305 |
2.1 |
- |
|
RPHM |
Reneo Pharmaceuticals, In... |
Director |
|
2023-05-08 |
4 |
B |
$8.00 |
$1,000,000 |
I/I |
125,000 |
2,188,713 |
2.1 |
% |
|
12 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|